Detalles de la búsqueda
1.
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Oncologist
; 29(1): e141-e151, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463014
2.
Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy.
Support Care Cancer
; 27(9): 3599, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087158
3.
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients.
Support Care Cancer
; 27(9): 3593-3597, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30762142
4.
Soft tissue sarcomas in the precision medicine era: new advances in clinical practice and future perspectives.
Radiol Med
; 124(4): 259-265, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29619613
5.
Hemodialysis and imatinib: Plasma levels, efficacy and tolerability in a patient with metastatic GIST - Case report.
Heliyon
; 10(7): e28494, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38596050
6.
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.
Front Oncol
; 13: 1141500, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37139149
7.
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.
Cancers (Basel)
; 15(1)2022 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36612211
8.
Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon.
Cancers (Basel)
; 13(5)2021 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33673554
9.
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
Cancers (Basel)
; 13(9)2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33925671
10.
A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming.
Cancers (Basel)
; 12(11)2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33207823
11.
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions.
Oncoimmunology
; 9(1): 1832348, 2020 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33178494
12.
Variation in Immune-Related microRNAs Profile in Human Milk Amongst Lactating Women.
Microrna
; 7(2): 107-114, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29412128
Resultados
1 -
12
de 12
1
Próxima >
>>